The Consumer Healthcare Products Association (CHPA) recently appointed Marina Karp as Director of Health Policy, a newly created position responsible for helping to develop the association’s overall health policy priorities including policy research and outreach to the broader healthcare community. Karp will help lead CHPA’s efforts to educate and engage payers and providers, and other stakeholders to reinforce and promote the critical value of OTCs, dietary supplements, and consumer medical devices to public health and wellness.
Prior to joining CHPA in June, Karp served as director of research at the Keckley Group, a healthcare research and policy analysis firm, where she focused on strategic growth initiatives and sustainability of health systems. Karp was also previously associate director of research at the Navigant Center for Healthcare Research & Policy Analysis, where she conducted primary research and developed thought leadership related to critical themes and trends impacting healthcare providers. Karp’s previous policy briefs and white papers have explored how legislative and regulatory changes impact key aspects of the healthcare delivery system.